Strides Arcolab said it has completed the sale of its Agila Specialties division to Mylan Inc for a total consideration of up to $1.75 bill...

US-based generic giant Mylan Inc’s $1.85-billion bid to acquire Indian drugmaker Agila Specialties now faces fresh riders, this time from i...

Mylan said the USFDA warning letter to Agila Specialties over violation of manufacturing norms in one of its plants will not affect the Rs ...

The decision was taken at a meeting of the Cabinet Committee of Economic Affairs held, Information and Broadcasting Minister Manish Tiwari ...

Since Mylan's investment proposal is of over Rs 1,200 crore, it will go to the Cabinet Committee on Economic Affairs for final approval.

US-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...

CCI has approved the acquisition of a Strides Arcolab subsidiary by Mylan, saying the deal will not have an adverse impact on competition i...

Pfizer's discussions with Strides Arcolab to acquire the latter's unit, Agila Specialties , is at a fairly advanced stage.

Eli Lilly and Company and Strides Arcolab inked a pact to increse delivery of cancer medicines in emerging markets.

Agila Specialties will manufacture the cancer medicines, and Lilly will register and market them in geographies across the emerging markets...

Strides Arcolab today said its injectables unit Agila Specialties has received US Food and Drug Administration (USFDA) approval for its Pol...

Global drug-makers including Novartis and Pfizer are among ‘serious bidders’ considering bidding for Bangalore-based Strides Arcolabs injec...

Strides Arcolabs' injectable drug division Agila Specialties Pharma Corporation has formed a 70:30 JV with Jamp Pharma to introduce injecta...

Strides today said it has received USFDA approval for its Brazilian plant that produces sterile dry powder anti-biotic injectables.

Drug firm Strides Arcolab said it has entered into an agreement with Bio-XCell Sdn Bhd for establishing a facility in Malaysia.

Drug firm Strides Arcolab today said it has received US health regulator's approval to market a product from its new facility in Karnataka.

Drug firm Strides Arcolab today said it has rebranded its specialities division, Strides Specialties as Agila Specialties, and that it will...